MyMigraineTeam

Qulipta (atogepant) is a daily oral medication specifically designed for preventing episodic migraines. It belongs to the newer class of anti-CGRP medications and studies show it can reduce monthly migraine days by an average of three to four days. Many MyMigraineTeam members have discussed their experiences with Qulipta Show Full Answer

Qulipta (atogepant) is a daily oral medication specifically designed for preventing episodic migraines. It belongs to the newer class of anti-CGRP medications and studies show it can reduce monthly migraine days by an average of three to four days. Many MyMigraineTeam members have discussed their experiences with Qulipta. The medication is taken once daily as a pill, making it convenient for long-term migraine management. Like other medications in its class, the most common side effects may include fatigue, upset stomach, and dry mouth. Qulipta works by blocking CGRP receptors, which helps prevent the migraine process from starting. This medication is now considered among first-line options for migraine prevention, representing an important advancement in migraine treatment.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

New Migraine Treatments: Medications, Devices, Anti-CGRP Drugs, and More (VIDEO)

What Is CGRP and How Does It Affect Migraine?